Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Shuang Wen"'
Publikováno v:
Translational Oncology, Vol 42, Iss , Pp 101900- (2024)
Resistance to chimeric antigen receptor (CAR) T-cell therapy remains a significant challenge in the treatment of solid tumors. This resistance is attributed to various factors, including antigen loss, immunosuppressive tumor microenvironment, and upr
Externí odkaz:
https://doaj.org/article/e607f019b1264fb99f832218a1d11324
Autor:
Shuang Wen, Xiao-Jie Ju, Wen-Ying Liu, Yu-Qiong Liu, Xing-Qun Pu, Zhuang Liu, Wei Wang, Rui Xie, Yousef Faraj, Liang-Yin Chu
Publikováno v:
Engineering, Vol 24, Iss , Pp 114-125 (2023)
A novel intestinal-targeted θ-shaped capsule with a pumping effect for the controlled release of hydrophobic drugs is successfully developed. The proposed capsule is composed of a Ca-alginate–chitosan/protamine/silica (ACPSi) composite shell and t
Externí odkaz:
https://doaj.org/article/1c3888b6feb54b90830adc70bbd36e5c
Publikováno v:
Case Studies in Thermal Engineering, Vol 49, Iss , Pp 103245- (2023)
As the additive manufacturing provides an advanced method for fabricating polymeric composite components in thermal engineering applications, the thermal contact conductance (TCC) between the contact composites can become an important problem. In ord
Externí odkaz:
https://doaj.org/article/b9dcb4c5d119401dbfcac224e0d56703
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 118, Iss , Pp - (2019)
Background Acute respiratory distress syndrome (ARDS), which is the severest form of pulmonary injury, is the leading cause of death in critical care. At present, the mortality remains high in ARDS. Partial liquid ventilation (PLV) using perfluorocar
Externí odkaz:
https://doaj.org/article/6d00438a3456423ebc9c9863833b1b90
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Ruiqi Zheng, Shuang Weng, Jianping Xu, Zhuo Li, Yaru Wang, Zulihumaer Aizimuaji, Sheng Ma, Linlin Zheng, Haiyang Li, Wantao Ying, Weiqi Rong, Ting Xiao
Publikováno v:
Computational and Structural Biotechnology Journal, Vol 21, Iss , Pp 3564-3574 (2023)
As sorafenib is a first-line drug for treating advanced hepatocellular carcinoma, sorafenib resistance has historically attracted attention. However, most of this attention has been focused on a series of mechanisms related to drug resistance arising
Externí odkaz:
https://doaj.org/article/3329a2098f694384bab273a36625cbbb